The company intends to use the funds to with capital to expand its wearable ultrasound product marketing and sales beyond the professional market and into the consumer arena.
Led by co-founder and Chief Executive Officer Bryant Guffey, and Chief Scientific and Technology Officer Dr. George K. Lewis, ZetrOZ recently introduced sam® sustained acoustic medicine www.samrecover.com and UltrOZ® www.ultroz.com, miniature wearable ultrasound devices for accelerated recovery and pain management. The sam® device addresses the demand for non-pharmaceutical and bio-regenerative alternatives to typical pharma-based pain treatments in the approximately $62 billion U.S. pain management market. Early adopters of sam® include physical therapists, athletic trainers and athletes for improved recovery of overuse injuries such as tendonopathies and muscle strains. UltrOZ™ Elite with OZ Inside™ launched in mid-2011 for use in the equestrian rehabilitation market for the treatment of common musculoskeletal conditions in horses.